ERT Delivers Insights to Identify COVID-related Trial Risks

Published on: 

Applied Clinical Trials

ERT has announced new reporting capabilities that help clinical trial sponsors and CROs ensure data collection during current global stay-home mandates. The Dashboard integrates data on coronavirus infection rates in geographic areas surrounding study investigative sites, so sponsors can identify and intervene where patient and site compliance to study protocols may be at risk.

For more information, click here.